SCHEMBL203138

SCHEMBL203138

CCN1N=C(c2ccc(NC(C)=O)cc2)CC1(C)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AR P10275 13/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL202310 0.90 AR (0.45) AR
SCHEMBL2755440 0.88 CYP1A2 (0.41) AR
SCHEMBL2702699 0.85 MKNK2 (0.38) AR
SCHEMBL202351 0.85 AR (0.48) AR
SCHEMBL203046 0.85 AR (0.48) AR
SCHEMBL202414 0.85 AR (0.48) AR
SCHEMBL201579 0.85 AR (0.48) AR
SCHEMBL203883 0.82 AR (0.47) AR
SCHEMBL13986515 0.81 AR (0.41) AR
SCHEMBL201907 0.80 PLA2G7 (0.42) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817292-B1 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) JANSSEN PHARMACEUTICA NV (BE) 2015-04-08 EP disclosed
US-8088811-B2 Heterocycle derivatives useful as selective androgen receptor modulators (SARMs) JANSSEN PHARMACEUTICA N.V. (BE) 2012-01-03 US disclosed